JPS5382777A - 55*substituted phenyl*oxazolidinone and sulfur homologue thereof process for preparing same and medicine containing same - Google Patents

55*substituted phenyl*oxazolidinone and sulfur homologue thereof process for preparing same and medicine containing same

Info

Publication number
JPS5382777A
JPS5382777A JP14492277A JP14492277A JPS5382777A JP S5382777 A JPS5382777 A JP S5382777A JP 14492277 A JP14492277 A JP 14492277A JP 14492277 A JP14492277 A JP 14492277A JP S5382777 A JPS5382777 A JP S5382777A
Authority
JP
Japan
Prior art keywords
same
oxazolidinone
substituted phenyl
medicine containing
homologue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14492277A
Other languages
Japanese (ja)
Other versions
JPS6154792B2 (en
Inventor
Fuuto Andoreasu
Shiyumiihien Rarufu
Keeru Buorufuganku
Pashieruke Geruto
Buahateru Herumuuto
Hansu Shiyunaidaa Heruberuto
Parenshiyaato Deiitaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762655369 external-priority patent/DE2655369A1/en
Priority claimed from DE19772745320 external-priority patent/DE2745320A1/en
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5382777A publication Critical patent/JPS5382777A/en
Publication of JPS6154792B2 publication Critical patent/JPS6154792B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
JP14492277A 1976-12-03 1977-12-02 55*substituted phenyl*oxazolidinone and sulfur homologue thereof process for preparing same and medicine containing same Granted JPS5382777A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762655369 DE2655369A1 (en) 1976-12-03 1976-12-03 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION
DE19772745320 DE2745320A1 (en) 1977-10-05 1977-10-05 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors

Publications (2)

Publication Number Publication Date
JPS5382777A true JPS5382777A (en) 1978-07-21
JPS6154792B2 JPS6154792B2 (en) 1986-11-25

Family

ID=25771221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14492277A Granted JPS5382777A (en) 1976-12-03 1977-12-02 55*substituted phenyl*oxazolidinone and sulfur homologue thereof process for preparing same and medicine containing same

Country Status (19)

Country Link
JP (1) JPS5382777A (en)
AT (1) AT357529B (en)
AU (1) AU519994B2 (en)
CA (1) CA1097657A (en)
CH (1) CH635578A5 (en)
CS (1) CS199694B2 (en)
DD (1) DD133667A5 (en)
DK (1) DK149850C (en)
FR (1) FR2372814A1 (en)
GB (1) GB1588639A (en)
GR (1) GR64964B (en)
HU (1) HU175676B (en)
IE (1) IE46435B1 (en)
IL (1) IL53520A (en)
IT (1) IT1089341B (en)
LU (1) LU78616A1 (en)
NL (1) NL7713153A (en)
SE (1) SE441446B (en)
SU (1) SU888821A3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0761978A (en) * 1984-10-19 1995-03-07 Schering Ag Oxazolidinone derivative

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701215C2 (en) * 1977-01-13 1982-10-14 Bayer Ag, 5090 Leverkusen Process for the preparation of thiazoline-2-thiones
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
JPH01135098U (en) * 1988-03-11 1989-09-14
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
WO1995017399A1 (en) * 1993-12-22 1995-06-29 Celltech Therapeutics Limited Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
WO1998028281A1 (en) * 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0761978A (en) * 1984-10-19 1995-03-07 Schering Ag Oxazolidinone derivative

Also Published As

Publication number Publication date
IT1089341B (en) 1985-06-18
CA1097657A (en) 1981-03-17
JPS6154792B2 (en) 1986-11-25
CH635578A5 (en) 1983-04-15
AU3117577A (en) 1979-06-07
IE772446L (en) 1978-06-03
IE46435B1 (en) 1983-06-15
FR2372814B1 (en) 1980-10-10
ATA868677A (en) 1979-12-15
GR64964B (en) 1980-06-10
SE441446B (en) 1985-10-07
DK536677A (en) 1978-06-04
IL53520A (en) 1981-07-31
SU888821A3 (en) 1981-12-07
CS199694B2 (en) 1980-07-31
DD133667A5 (en) 1979-01-17
GB1588639A (en) 1981-04-29
NL7713153A (en) 1978-06-06
LU78616A1 (en) 1978-04-20
HU175676B (en) 1980-09-28
IL53520A0 (en) 1978-03-10
DK149850C (en) 1987-04-27
FR2372814A1 (en) 1978-06-30
AU519994B2 (en) 1982-01-07
SE7713635L (en) 1978-06-04
DK149850B (en) 1986-10-13
AT357529B (en) 1980-07-10

Similar Documents

Publication Publication Date Title
JPS5382777A (en) 55*substituted phenyl*oxazolidinone and sulfur homologue thereof process for preparing same and medicine containing same
PT67017B (en) Process for preparing novel heterocyclic compounds and herbicide compositions thereof
JPS52122632A (en) Medical composition and process for preparing same
JPS5446786A (en) Novel 3*4*55trihydroxypiperidine compound* its manufacture and use for medicine
HU172935B (en) Process for preparing furancarbonyl-anilides and microbicide agents further agents regulating plant growth containing such compounds
JPS5315436A (en) Fluorooterpolymer contained hair fixation compound and process for hair fixation
JPS52136195A (en) Novel 2*33dihydrooimidazo*2*11b** thiazole derivatives and process for preparing same
JPS52116446A (en) Novel sulfonamide process for preparing same and medicine containing same
JPS52125193A (en) Indolysine derivatives process for preparing same and medicine containing same
EG14649A (en) Process for preparing of n'-benzoyl n'-pyridyloxy phenyl urea
JPS55149128A (en) Method and device for preparing 195 mau contained liquid
JPS54157570A (en) Nnoxacycliccalkylpiperizylldiaza compounds* these manufactures and medicine containing them
JPS5318544A (en) Novel phenyl phosphite process for preparing and stabilized organic material composition containing same
JPS5384973A (en) 1*3*44oxadiazole process for preparing same and application thereof
JPS5436225A (en) Novel 1*33diphenoxypropanee22one derivative process for preparing same and medicine containing same
JPS53149974A (en) Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same
JPS52118492A (en) Novel amidinopenicillanoyl oxyalkylamoxylinate salts thereof process for preparing same and pharmaceutical composition containing same
JPS52151104A (en) Stabilizing composition for 1*1*11trichloroethane and process for preparing same
JPS5677244A (en) Novel substituted 1*33diphenoxypropanoll2 derivative* its manufacture and medicine containing it
JPS52139096A (en) Novel phosphite process for preparing same and stabilizer containing same
PT66846B (en) Process for preparing an insecticidal acaricidal and nematocidal composition containing o-ethyl-s-n-propyl-o,2,2-trihaloethylphosphorothiolates (or thionothiolates)
JPS5379872A (en) Process for preparing novel substituted 55aminoo22pyridine*arboxylate compound and medical composition containing same
JPS53130682A (en) Novel 11*33*3*4*55trimethoxyphenoxy**22 hydroxyypropyl**44aryllpiperazine derivative process for preparing same and medicine containing same
JPS52148096A (en) Medicine novel heterocyclic compound containing therein and process for preparing same
PH14954A (en) 2-(6'-carboxy-n-hexyl)-3-n-hexyl-cyclopentanol and derivatives or analogs thereof